Company Filing History:
Years Active: 1991
Title: Mary Ellen Salvan: Innovator in Glycolipid Structures
Introduction
Mary Ellen Salvan is a prominent inventor based in Seattle, WA. She has made significant contributions to the field of biochemistry, particularly in the development of glycolipid structures. Her work has implications for immunology and cancer treatment.
Latest Patents
Mary Ellen Salvan holds a patent for a long-chain glycolipid structure. This patent describes a substantially pure unbranched ceramide polysaccharide type 2 chain compound. The compound has a specific structure involving galactose, N-acetylglucosamine, fucose, glucose, ceramide, and sialic acid. Additionally, the patent includes antibodies that are specific to portions of these compounds, which can be used for immunization against tumors expressing these structures.
Career Highlights
Mary Ellen is associated with The Biomembrane Institute, where she continues her research and development efforts. Her innovative work has led to advancements in understanding complex carbohydrate structures and their biological functions.
Collaborations
She has collaborated with notable colleagues, including Edward D Nudelman and Steven B Levery. These partnerships have enhanced her research and contributed to the scientific community's understanding of glycolipids.
Conclusion
Mary Ellen Salvan's contributions to the field of biochemistry, particularly through her patented innovations, highlight her role as a leading inventor. Her work continues to influence research in immunology and cancer therapies.